-
公开(公告)号:GR3021170T3
公开(公告)日:1996-12-31
申请号:GR960402518
申请日:1996-09-26
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING LEUNG , ZHAO CHEN , SOWIN THOMAS J , RENO DANIEL S , HAIGHT ANTHONY R , COOPER ARTHUR J
IPC: C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/32 , C07D263/48 , C07D265/30 , C07D277/22 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
Abstract: A retroviral protease inhibiting compound of formula (A) is disclosed for use in combination with other active pharmaceutical agents for treating a human infected by HIV. Intermediates and processes useful in the manufacture of compounds of formula (A) are also disclosed.
-
公开(公告)号:AU3150395A
公开(公告)日:1996-03-07
申请号:AU3150395
申请日:1995-07-26
Applicant: ABBOTT LAB
Inventor: ZHAO CHEN , KEMPF DALE J , SHAM HING L , NORBECK DANIEL W , BETEBENNER DAVID A , LIN SHUQUN
IPC: C07C281/02 , C07D255/02 , C07D405/06 , C07D405/14 , C07D413/14 , C07D417/14 , A61K31/55 , C07D295/08 , C07D403/06 , C07D413/06 , C07D417/06 , C07F7/08
-
公开(公告)号:AU645493B2
公开(公告)日:1994-01-20
申请号:AU5571190
申请日:1990-05-18
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , ERICKSON JOHN W , SHAM HING LEUNG , CODACOVI LYNN M , PLATTNER JACOB J
IPC: C07D295/18 , A61K31/00 , A61K31/10 , A61K31/12 , A61K31/135 , A61K31/15 , A61K31/165 , A61K31/195 , A61K31/335 , A61K31/40 , A61K31/415 , A61K31/425 , A61K31/44 , A61K31/445 , A61K31/47 , A61K31/495 , A61K31/535 , A61K31/54 , A61K38/00 , A61P31/12 , A61P37/04 , C07C31/125 , C07C33/18 , C07C33/26 , C07C33/46 , C07C39/12 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/313 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/59 , C07C45/62 , C07C45/67 , C07C45/74 , C07C49/04 , C07C49/12 , C07C49/17 , C07C49/175 , C07C49/20 , C07C49/215 , C07C49/233 , C07C49/24 , C07C49/255 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/06 , C07C215/18 , C07C215/20 , C07C215/28 , C07C217/04 , C07C225/06 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/35 , C07C233/36 , C07C233/40 , C07C233/78 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/04 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/08 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/00 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/05 , C07C311/06 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/11 , C07C323/12 , C07C323/25 , C07C323/41 , C07C323/60 , C07C381/00 , C07D207/06 , C07D207/08 , C07D207/12 , C07D207/16 , C07D207/24 , C07D209/42 , C07D211/22 , C07D211/54 , C07D211/62 , C07D211/96 , C07D213/30 , C07D213/40 , C07D213/42 , C07D213/55 , C07D213/56 , C07D213/70 , C07D213/81 , C07D213/82 , C07D215/16 , C07D217/14 , C07D217/16 , C07D217/26 , C07D231/10 , C07D233/60 , C07D233/61 , C07D233/84 , C07D239/38 , C07D263/06 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/36 , C07D277/42 , C07D277/56 , C07D279/12 , C07D295/088 , C07D295/14 , C07D295/15 , C07D295/155 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/22 , C07D295/26 , C07D303/04 , C07D303/22 , C07D303/36 , C07D303/48 , C07D305/14 , C07D307/42 , C07D317/12 , C07D413/12 , C07D417/12 , C07D487/04 , C07D521/00 , C07F7/02 , C07F9/30 , C07F9/32 , C07F9/53 , C07K5/02 , C07K5/04 , C07K5/06 , C07K5/062 , C07K5/078 , C07D215/48 , C07D303/24 , C07D295/195 , C07C307/06 , C07C205/37 , C07C311/14 , C07C33/24 , C07C229/16 , C07C49/245 , C07C59/56
Abstract: A retroviral protease inhibiting compound of the formula A - X - B or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein X is a linking group; A is (1) substituted amino, (2) substituted carbonyl, (3) functionalized imino, (4) functionalized alkyl, (5) functionalized acyl, (6) functionalized heterocyclic or (7) functionalized (heterocyclic)alkyl; and B is (1) substituted carbonyl independently defined as herein, (2) substituted amino independently defined as herein, (3) functionalized imino independently defined as herein, (4) functionalized alkyl independently defined as herein, (5) functionalized acyl independently defined as herein, (6) functionalized heterocyclic independently defined as herein or (7) functionalized (heterocyclic)alkyl independently defined as herein. o
-
公开(公告)号:PT99545A
公开(公告)日:1992-09-30
申请号:PT9954591
申请日:1991-11-19
Applicant: ABBOTT LAB
Inventor: SHAM HING L , PLATTNER JACOB J , NORBECK DANIEL W , KEMPF DALE J , CODACOVI LYNN M , WITTENBERGER STEVEN J , ZHAO CHEN
IPC: A61K31/42 , A61K31/421 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/435 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/443 , A61K31/444 , A61K38/00 , A61P31/12 , A61P31/18 , A61P43/00 , C07C53/134 , C07C211/00 , C07C215/18 , C07C215/20 , C07C215/28 , C07C215/30 , C07C215/80 , C07C219/18 , C07C233/40 , C07C237/10 , C07C237/22 , C07C269/04 , C07C271/02 , C07C271/16 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/24 , C07D20060101 , C07D213/00 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/36 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D213/79 , C07D215/20 , C07D233/54 , C07D233/84 , C07D235/14 , C07D235/16 , C07D237/10 , C07D239/26 , C07D241/12 , C07D261/08 , C07D261/12 , C07D263/20 , C07D263/32 , C07D277/20 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/02 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/34 , C07D307/42 , C07D307/66 , C07D333/16 , C07D333/36 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D521/00 , C07K1/113 , C07K5/06 , C07K5/065 , C07K5/08 , C07K14/81 , C07C , C07D , A61K
Abstract: An intermediate of the formula: and an intermediate of the formula: or an acid addition salt thereof.M
-
公开(公告)号:CA1307289C
公开(公告)日:1992-09-08
申请号:CA615975
申请日:1991-01-08
Applicant: ABBOTT LAB
Inventor: LULY JAY R , PLATTNER JACOB J , KEMPF DALE J
IPC: C07C215/10 , A61K31/16 , A61K31/165 , A61K31/18 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/33 , A61K31/535 , A61K31/5375 , A61K38/00 , A61P9/12 , A61P43/00 , C07C67/00 , C07C213/00 , C07C215/20 , C07C215/26 , C07C215/28 , C07C217/44 , C07C231/00 , C07C231/12 , C07C235/06 , C07C235/08 , C07C235/10 , C07C235/74 , C07C237/08 , C07C237/10 , C07C237/22 , C07C239/00 , C07C269/00 , C07C271/16 , C07C273/10 , C07C301/00 , C07C303/30 , C07C303/40 , C07C309/63 , C07C311/00 , C07C313/00 , C07C323/60 , C07D233/54 , C07D233/64 , C07D241/24 , C07D295/18 , C07D521/00 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/065 , C07K5/083 , C07K5/097 , C07K14/81 , C12N9/99
Abstract: The present application discloses compounds of formula: wherein R is lower alkyl, cycloalkylmethyl or benzyl; R' is H, loweralkyl, vinyl or arylalkyl; P2 and P3 are independently selected from H or an O-protecting group; and P1 is H or an N-protecting group; or acid addition salts thereof. The compounds of the present invention are useful as intermediates for the preparation of renin inhibiting compounds.
-
公开(公告)号:MX9203679A
公开(公告)日:1992-07-01
申请号:MX9203679
申请日:1992-06-29
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , ERICKSON JOHN W , SHAM HING LEUNG , PLATTNER JACOB J
IPC: C12N9/99
-
公开(公告)号:DK514688D0
公开(公告)日:1988-09-15
申请号:DK514688
申请日:1988-09-15
Applicant: ABBOTT LAB
Inventor: ROSENBERG SAUL HOWARD , SHAM HING LEUNG , BAKER WILLIAM R , DELLARIA JR JOSEPH F , KEMPF DALE J
IPC: C07C271/10 , A61K31/395 , A61K31/415 , A61K31/42 , A61K31/421 , A61K31/535 , A61K31/536 , A61K31/5375 , A61K31/5377 , A61K31/538 , A61K31/54 , A61K38/00 , A61P9/12 , C07C67/00 , C07C69/24 , C07C213/00 , C07C215/10 , C07C215/20 , C07C215/28 , C07C217/08 , C07C217/28 , C07C229/22 , C07C229/26 , C07C229/30 , C07C229/32 , C07C229/34 , C07C229/36 , C07C231/00 , C07C231/02 , C07C233/11 , C07C233/22 , C07C233/40 , C07C233/47 , C07C233/51 , C07C235/20 , C07C237/12 , C07C237/20 , C07C239/20 , C07C255/46 , C07C265/02 , C07C265/04 , C07C271/16 , C07C271/20 , C07C271/22 , C07C275/24 , C07C317/28 , C07C317/44 , C07C317/48 , C07C323/24 , C07C323/41 , C07C323/56 , C07C323/59 , C07C323/60 , C07D207/12 , C07D211/76 , C07D213/40 , C07D233/32 , C07D233/61 , C07D263/04 , C07D263/06 , C07D263/16 , C07D263/22 , C07D263/24 , C07D263/28 , C07D265/10 , C07D273/04 , C07D277/24 , C07D285/10 , C07D295/12 , C07D295/13 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/22 , C07D309/14 , C07D319/06 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07K5/02 , C07K5/06 , C07K5/065 , C07K5/08 , C07C125/063 , C07C91/02 , C07C101/04 , C07C103/34 , C07C147/06 , C07C149/273 , C07D207/04 , C07D231/12 , C07D233/64 , C07D239/10 , C07D241/02 , C07D263/18 , C07D265/30 , C07D277/30 , C07D291/04 , C07K5/04
Abstract: A renin inhibiting compound of the formula: wherein A is a substituent; W is C=O, CHOH or NR2 wherein R2 is hydrogen or loweralkyl; U is C=O, CH2 or NR2 wherein R2 is hydrogen or loweralkyl, with the proviso that when W is CHOH then U is CH2 and with the proviso that U is C=O or CH2 when W is NR2; V is CH, C(OH) or C(halogen) with the proviso that V is CH when U is NR2; R1 is loweralkyl, cycloalkylalkyl, benzyl, (alpha, alpha)-dimethylbenzyl, 4-methoxybenzyl, halobenzyl, 4-hydroxybenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (unsubstituted heterocyclic)methyl, (substituted heterocyclic)methyl, phenethyl, 1-benzyloxyethyl, phenoxy, thiophenoxy or anilino, provided that B is CH2 or CHOH or A is hydrogen when R1 is phenoxy, thiophenoxy or anilino; R3 is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)alkyl, carboxyalkyl, (thioalkoxy)alkyl, azidoalkyl, aminoalkyl, (alkyl)aminoalkyl, dialkylaminoalkyl, (alkoxy)(alkyl)aminoalkyl, (alkoxy)aminoalkyl, benzyl or heterocyclic ring substituted methyl; R4 is loweralkyl, cycloalkylmethyl or benzyl; R5 is OH or NH2; and Z is a substituent. Also disclosed are compositions for and a method of treating hypertension, methods of making the renin inhibiting compounds and intermediates useful in making the renin inhibiting compounds.
-
78.
公开(公告)号:AR086181A2
公开(公告)日:2013-11-27
申请号:ARP120101342
申请日:2012-04-19
Applicant: ABBOTT LAB , ENANTA PHARM INC
Inventor: MDANIEL KEITH F , CHEN HUI , JU-SHANLEY JASON P , GAI YONGHUA , KEMPF DALE J , GRAMPOVNIK DAVID J , SUN YING , LIU DONG , WAGAW SABLE H , ENGSTROM KEN , GRIEME TIM , KU YIYIN , OR YAT SUN
Abstract: Reivindicación 1: Un método para producir un compuesto de fórmula (1), o una sal farmacéuticamente aceptable del mismo, caracterizada porque comprende el paso de hacer reaccionar un compuesto de fórmula (2), donde, J es -C(O)-; A es heteroarilo opcionalmente sustituido; G es -E-R5; donde E es -N(R3)S(Op)-; p es 2; R5 es carbociclo opcionalmente sustituido; cada R3 es hidrógeno; L se encuentra ausente; j = 2; k = 2; m = 1; y - - - - - denota una unión carbono-carbono doble; y LG es un grupo saliente; con un compuesto de fórmula (3), donde: cada R1 se selecciona independientemente entre (i) halógeno, hidroxi, amino, -CN, -CF3, -N3, -NO2, -OR4, -SR4, -SOR4, -SO2R4, -N(R3)S(O)2-R4, -N(R3)S(O2)NR3R4, -NR3R4, -C(O)OR4, -C(O)R4, -C(O)NR3R4, o -N(R3)C(O)R4; (ii) arilo opcionalmente sustituido; (iii) heteroarilo opcionalmente sustituido; (iv) heterociclo opcionalmente sustituido; (v) carbociclo opcionalmente sustituido; o (vi) alquilo opcionalmente sustituido, alquenilo opcionalmente sustituido, o alquinilo opcionalmente sustituido, cada uno con 0, 1, 2, ó 3 heteroátomos seleccionados entre O, S, o N; R3 y R4 cada uno se selecciona independientemente en cada oportunidad entre los siguientes: alquilo opcionalmente sustituido, alquenilo opcionalmente sustituido o alquinilo opcionalmente sustituido, cada uno con 0, 1, 2, ó 3 heteroátomos seleccionados entre O, S, o N; arilo opcionalmente sustituido; heteroarilo opcionalmente sustituido; heterociclo opcionalmente sustituido; carbociclo opcionalmente sustituido; o hidrógeno; n es 0, 1, 2, 3, ó 4; Y es CR’’; donde R’ y R’’ juntos forman un anillo arilo; para de esa manera producir un compuesto de fórmula (1).
-
公开(公告)号:ES2426965T3
公开(公告)日:2013-10-28
申请号:ES10176829
申请日:2004-11-10
Applicant: ABBOTT LAB , ABBVIE INC
Inventor: FLENTGE CHARLES A , CHEN HUI-JU , DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , HUANG PEGGY P , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , MADIGAN DAROLD L , RANDOLPH JOHN T , SUN MINGHUA , YEUNG MING C , ZHAO CHEN
IPC: C07D417/06 , A61K31/175 , A61K31/18 , A61K31/195 , A61K31/277 , A61K31/4166 , A61K31/4168 , A61K31/4178 , A61K31/65 , A61K45/06 , A61P31/18 , C07C311/17 , C07D213/30 , C07D213/40 , C07D213/78 , C07D233/32 , C07D233/72 , C07D277/28 , C07D277/46 , C07D277/48 , C07D307/20 , C07D307/42 , C07D401/06 , C07D403/06 , C07D403/10 , C07D405/06 , C07D405/10 , C07D409/06 , C07D417/14 , C07D471/04 , C07D493/04
Abstract: Un compuesto que tiene la fórmula (V)**Fórmula** o una forma de sal farmacéuticamente aceptable, estereoisómero, éster, sal de un éster, o combinación de éstos, enel que X es O, S o NH; Y es O, S o NH; R es alquilo, alquenilo, cicloalquilo, cicloalquenilo, cicloalquilalquilo, cicloalquenilalquilo, arilalquilo o heteroarilalquilo;en el que cada R está sustituido con 0, 1 ó 2 sustituyentes seleccionados del grupo que consiste en alquilo,alquenilo, alquinilo, ciano, halo, formilo, nitro, hidroxi, alcoxi, -NH2, -N(H)alquilo, -N(alquilo)2, -C(>=O)OH,-C(>=O)Oalquilo, haloalquilo, hidroxialquilo y alcoxialquilo; R1 es ORa, -OSO2Ra, -OSO3Ra, -OPO3Ra, -OC(>=O)C(H)(R1a)NRaRb o -OC(>=O)C(H)(R1a)N(H)C(O)ORa;R1a es hidrógeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroarilo oheteroarilalquilo; en el que cada R1a está sustituido con 0, 1 ó 2 sustituyentes seleccionados independientemente delgrupo que consiste en halo, alquilo, alquenilo, alquinilo, -ORa, -SRa, -SORa, -SO2Ra, -SO2NRaRb, -C(>=O)Ra, -NRaRb,-N(Rb)C(>=O)Ra, -N(Rb)C(>=O)ORa, -N(Rb)SO2Ra, -N(Ra)SO2NRaRb, -N(Rb)C(>=NH)NRaRb, -N(Rb)C(>=O)NRaRb,-C(>=O)NRaRb y -C(>=O)ORa; R2 es H; R3 es alquilo, haloalquilo, alquenilo, haloalquenilo, alquinilo, haloalquinilo, cicloalquilo, cicloalquenilo,cicloalquenilalquilo, cicloalquilalquilo, heterociclo, heterocicloalquilo, heteroarilo, heteroarilalquilo, arilo, arilalquilo,hidroxialquilo, alcoxialquilo, haloalcoxialquilo, -alquiloSRa, -alquiloSORa, -alquiloSO2Ra, -alquiloNRaRb,-alquiloN(Rb)C(>=O)ORa, -alquiloN(Rb)C(>=O)Ra, -alquiloN(Rb)SO2Ra o -alquiloN(Rb)SO2NRaRb; en el que cada uno delos restos cicloalquilo, cicloalquenilo, arilo, heteroarilo, heterociclo, cicloalquilo del cicloalquilalquilo, restocicloalquenilo del cicloalquenilalquilo, resto heterociclo del heterocicloalquilo, resto heteroarilo del heteroarilalquilo,resto arilo del arilalquilo está sustituido independientemente con 0, 1, 2 ó 3 sustituyentes seleccionadosindependientemente del grupo que consiste en halo, nitro, ciano, formilo, alquilo, alquenilo, alquinilo, hidroxi, alcoxi,-SH, -S(alquilo), -SO2(alquilo), -NH2, -N(H)(alquilo), - N(alquilo)2, -N(H)C(>=O)alquilo, -N(alquilo)C(>=O)alquilo,-C(>=O)OH, -C(>=O)O(alquilo), -C(>=O)NH2, -C(>=O)N(H)(alquilo), -C(>=O)N(alquilo)2, -C(>=O)alquilo, haloalquilo,hidroxialquilo, alcoxialquilo, cianoalquilo, formilalquilo, nitroalquilo, -alquiloSH, -alquiloS(alquilo), -alquiloSO2(alquilo),-alquiloNH2, -alquiloN(H)(alquilo), -alquiloN(alquilo)2, -alquiloN(H)C(>=O)alquilo, -alquiloN(alquilo)C(>=O)alquilo,-alquiloC(>=O)OH, -alquiloC(>=O)O(alquilo), -alquiloC(>=O)NH2, -alquiloC(>=O)N(H)(alquilo), -alquiloC(>=O)N(alquilo)2,-alquiloC(>=O)alquilo y R3a.
-
公开(公告)号:BRPI0918724A2
公开(公告)日:2013-06-18
申请号:BRPI0918724
申请日:2009-09-10
Applicant: ENANTA PHARM INC , ABBOTT LAB
Inventor: KU YIYIN , MCDANIEL KEITH F , CHEN HUI-JU , SHANLEY JASON P , KEMPF DALE J , GRAMPOVNIK DAVID J , SUN YING , LIU DONG , GAI YONGHUA , OR YAT SUN , WAGAN SABLE H , ENGSTROM KEN , GRIEME TIM , SHEIKH AHMAD , MEI JIANZHANG
Abstract: The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
-
-
-
-
-
-
-
-
-